How long should you be on Wegovy for weight loss?

The NHS two-year rule and what it means for you

If you access Wegovy through an NHS specialist weight management service, NICE's appraisal of semaglutide (TA875) sets a maximum treatment duration of two years. That limit is specific to NHS commissioning; it reflects the conditions under which NICE judged the medicine cost-effective within specialist services, not a biological ceiling on how long the drug can safely be used. Private prescribers are not bound by the same two-year cap, but that does not make indefinite treatment automatic. Every repeat prescription at nume is reviewed on its clinical merits, no prescription renews on autopilot.

The two-year framing is worth understanding properly, and if you want a thorough breakdown, our page on how long you should take Wegovy covers the clinical reasoning in full. It emerged partly because the longest trials ran to 68 weeks, so evidence beyond that window, while growing, is less extensive. It also reflects an NHS resource judgement. If you are considering private treatment, the question to ask is not "how long am I allowed" but "how long does my clinical picture support continuing?"

If weight loss stalls below 5% of your starting body weight after six months at the highest dose you can tolerate, both NICE and clinical common sense point toward stopping and reassessing. That threshold exists because the medicine is doing real metabolic work, not just suppressing appetite; if it is not working at that level, continuing carries cost and side-effect risk for little return.

How your response in the first year shapes the long-term picture

The STEP 1 trial, published in the New England Journal of Medicine, found that adults on semaglutide 2.4mg lost an average of around 15% of body weight over 68 weeks alongside lifestyle changes. Most of that loss happened in the first 12 months; the second half of the trial saw slower, consolidating progress. That pattern matters for thinking about duration.

The first year is typically when the medicine does the heaviest lifting, appetite suppression is strongest, portion sizes shrink naturally, and the combination of lower energy intake and any increase in activity compounds. By month 12 to 18, many people find their weight has plateaued at a new level. That plateau is not failure; it is biology. The question then becomes whether holding that reduced weight, with its metabolic and cardiovascular benefits, is itself a reason to continue.

You can explore the broader picture of how long Wegovy takes to work on its own page, but the short version is: expect meaningful change within the first four to eight weeks, with the bulk of weight loss over the following nine to twelve months. Duration decisions look different depending on where you are in that curve.

Stopping Wegovy: what the evidence says happens next

This is the part many people ask about, often quietly, because it raises an uncomfortable question about dependency. The honest clinical answer is that weight regain after stopping semaglutide is well documented. A withdrawal study following the STEP 1 trial found that participants who stopped the medicine regained most of the weight they had lost within about a year. That finding does not mean the medicine failed. It reflects the biology of a chronic condition.

Stopping is not always the wrong call. Some people reach a weight that, combined with durable lifestyle changes, they can maintain without the medicine. Others use Wegovy as a bridge, long enough to reduce weight-related health risks, establish different habits around food, and build a sustainable routine. A few people will need ongoing treatment in the same way someone with hypertension stays on antihypertensive medication.

The decision is best made with a prescriber who knows your full picture, rather than based on a fixed time limit. If you are thinking about what staying on semaglutide for the longer term looks like, this page covers the clinical context in more depth. And if you're mid-treatment and wondering whether your current progress is on track, the nume FAQs page addresses several common questions prescribers hear.

Making the decision alongside a prescriber

How long you stay on Wegovy is ultimately a clinical question, shaped by four things: how much weight you've lost, whether that loss has translated into meaningful health improvements (blood pressure, blood sugar, joint pain, sleep quality), how well you've tolerated the medicine, and whether you've been able to build habits that could support your weight independently. If you are weighing up that question right now, our dedicated page on how long you should be on Wegovy walks through each of these factors in detail. A good prescriber weighs all of these together.

At nume, a GPhC-registered Independent Prescriber reviews every repeat order before it is dispensed. There is no algorithm waving prescriptions through at renewal. If the clinical picture has changed (a new medication, a pregnancy consideration, a period where the medicine was paused) that gets factored in. The process is the same whether you're on your second pen or your twelfth.

Private treatment also means you are not constrained by NHS phasing or waiting lists. You might start treatment now, at a BMI and health status that qualifies for a private clinical consultation, and review duration at each follow-up rather than being given a fixed endpoint from the start. That flexibility is one of the practical differences between the private and NHS routes.

For context on how Wegovy fits into the broader landscape of weight management options, the Wegovy treatment page covers eligibility, the prescribing process and what to expect. And if cost is part of your thinking, the Wegovy pricing page sets out what private treatment typically involves.